Capecitabine in combination with trastuzumab appears to be of benefit in advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Bevacizumab combo keeps breast cancer under control

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Trastuzumab combo questions use of doxorubicin in breast cancer

By  

Inpharma, Vol. 1, Iss. 1527, 2006-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Novel Approaches to Advanced Breast Cancer: Bevacizumab and Lapatinib

By Mayer Erica L.   Lin Nancy U.   Burstein Harold J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 3, 2007-03 ,pp. : 314-323

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The antiangiogenic agent AE 941 [`Neovastat'] provides clinical benefit in prostate cancer

By  

Inpharma, Vol. 1, Iss. 1295, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite